Sleep Disorder Unit, Pitie-Salpetriere Hospital, AP-HP, Paris, France(1); Sorbonne University, Paris, France; Faculty of Medicine of Sfax, Sfax University, Sfax, Tunisia.
Sleep Disorder Unit, Pitie-Salpetriere Hospital, AP-HP, Paris, France(1); Chest Department, Compiegne General Hospital, Compiegne, France.
Sleep Med. 2018 Feb;42:53-60. doi: 10.1016/j.sleep.2017.12.008. Epub 2018 Jan 8.
To determine the frequency of sleep breathing disorders in multiple systemic atrophy (MSA, combining Parkinsonism, cerebellar syndrome, and dysautonomia) and evaluate the benefit/tolerance of various modes of ventilation.
We retrospectively analyzed 45 patients with MSA having undergone a videopolysomnography. Their sleep characteristics were compared to those of 45 patients with Parkinson's disease and 45 healthy controls, matched for age and sex. Patients with MSA received fixed continuous positive airway pressure (CPAP) when stridor was isolated, auto-adjusting CPAP when it was combined with obstructive sleep apnea, and adaptive servo-ventilation (ASV) when combined with central sleep apnea.
Higher periodic leg movements index and more frequent REM sleep behavior disorder were observed in MSA patients, compared to patients with Parkinson's disease and healthy controls. In MSA, 28/45 (62.2%) patients had sleep breathing disorders, including (overlapping samples) stridor (n = 17, 38%), obstructive sleep apnea (n = 14, 31%), central sleep apnea (n = 4, 9%), and ataxic breathing (n = 1). Except for three initial refusals and two yet untreated patients, fixed CPAP (n = 9), auto-adjusting CPAP (n = 8) and ASV (n = 2) were well-tolerated (limited leaks and good compliance) and successfully controlled stridor plus sleep apnea. Treated patients had survival times similar to those of patients without any sleep breathing disorder.
In this small group, tailored management of stridor in MSA as an independent issue or combined with obstructive and central sleep apnea, yields a survival similar to survival in patients without sleep breathing disorders.
确定多系统萎缩症(MSA,结合帕金森病、小脑综合征和自主神经功能障碍)患者睡眠呼吸障碍的频率,并评估各种通气模式的获益/耐受性。
我们回顾性分析了 45 例接受视频多导睡眠图检查的 MSA 患者。将他们的睡眠特征与 45 例帕金森病患者和 45 例健康对照者进行比较,这些对照者在年龄和性别上相匹配。孤立性喘鸣患者接受固定持续气道正压通气(CPAP),合并阻塞性睡眠呼吸暂停患者接受自动调节 CPAP,合并中枢性睡眠呼吸暂停患者接受适应性伺服通气(ASV)。
与帕金森病患者和健康对照组相比,MSA 患者的周期性肢体运动指数更高,快速眼动睡眠行为障碍更频繁。在 MSA 中,28/45(62.2%)例患者存在睡眠呼吸障碍,包括(重叠样本)喘鸣(n=17,38%)、阻塞性睡眠呼吸暂停(n=14,31%)、中枢性睡眠呼吸暂停(n=4,9%)和共济失调性呼吸(n=1)。除了 3 例最初拒绝和 2 例尚未治疗的患者外,固定 CPAP(n=9)、自动调节 CPAP(n=8)和 ASV(n=2)均耐受良好(限制漏气和良好依从性),成功控制了喘鸣加睡眠呼吸暂停。治疗患者的生存时间与无任何睡眠呼吸障碍患者相似。
在这个小样本中,针对 MSA 患者喘鸣这一独立问题或与阻塞性和中枢性睡眠呼吸暂停联合进行个体化管理,可获得与无睡眠呼吸障碍患者相似的生存时间。